Clearbridge Health Ltd Stock Singapore S.E.
Equities
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
||
- SGD | - |
|
Apr. 29 | Clearbridge Health Awards Shares Under Performance Share Plan | MT |
Feb. 29 | Clearbridge Health Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2022 | 16.41M 12.22M | Sales 2023 | 11.49M 8.56M | Capitalization | 9.9M 7.38M |
---|---|---|---|---|---|
Net income 2022 | -11M -8.19M | Net income 2023 | -32M -23.83M | EV / Sales 2022 | 1.49 x |
Net Debt 2022 | 913K 680K | Net Debt 2023 | 2.5M 1.86M | EV / Sales 2023 | 1.08 x |
P/E ratio 2022 |
-2.11
x | P/E ratio 2023 |
-0.31
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 53.05% |
Managers | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Wei Chee Tan
AUD | Comptroller/Controller/Auditor | 39 | 22-09-30 |
Hui Yee Cheok
SEC | Corporate Secretary | - | 22-06-23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jeremy Yee
CEO | Chief Executive Officer | 54 | 17-05-14 |
Mark Ryan
BRD | Director/Board Member | 57 | 17-11-19 |
Andrew Lord
BRD | Director/Board Member | 65 | 17-11-19 |
1st Jan change | Capi. | |
---|---|---|
+17.30% | 82.59B | |
-26.28% | 72.22B | |
-1.34% | 26.41B | |
+4.17% | 17.69B | |
-9.26% | 16.89B | |
+4.08% | 15.6B | |
+76.90% | 13.7B | |
+76.96% | 12.77B | |
-25.96% | 12.76B |